Diabetes :: Indigenous people are not genetically prone to diabetes
The high rate of diabetes among indigenous people is not due to their genetic heritage, according to a recently published study.
People
Multiple Sclerosis :: MS patients not receiving medications to slow disease progression
Neurologists at Wake Forest University Baptist Medical Center have found that many patients diagnosed with multiple sclerosis are not taking or being prescribed drugs approved to treat the disease.
Obesity :: Geisinger launches extensive study on obesity and related liver problem
Relying on one of the largest collections of liver tissue samples ever acquired by a single organization, Geisinger Health System researchers have embarked on a massive study of one of the fastest growing liver problems.
Grant :: Tennessee researcher earns Komen grant to study depression and breast cancer
A new grant from the Susan G. Komen Breast Cancer Foundation will allow a University of Tennessee professor to conduct a groundbreaking study into how best to treat well diagnosed depression in breast cancer patients.
Impetigo :: GSK announces FDA approval of Altabax for the topical treatment of impetigo
GlaxoSmithKline (NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.
Obesity :: Childhood obesity among Quebec Cree raises concerns
Childhood obesity is increasing among the general population in Canada, but the statistics are even more alarming among First Nations, Inuit and M?tis children.
Chagas Disease :: Bayer helps WHO expand fight against Chagas Disease
The World Health Organization (WHO) is expanding the global effort to eliminate Chagas, a parasitic disease which affects an estimated nine million people, mostly children.
Diabetes :: deCODE T2 – a DNA-based test for assessing Type 2 Diabetes
deCODE genetics, Inc. (Nasdaq:DCGN) announced the launch of deCODE T2?, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
Crohn’s Disease :: Genetic risk factors for Crohn’s disease identified
An international research team ? including investigators from Massachusetts General Hospital (MGH) and the Broad Institute of Harvard University and Massachusetts Institute of Technology ? has identified several novel genetic variations associated with the risk of Crohn’s disease.
Colorectal Cancer :: Diet, lifestyle affect colorectal adenoma recurrence
Experts agree that people who have had three or more potentially precancerous adenomatous polyps removed during a colonoscopy should be “rescoped” in three years to make sure the polyps do not recur.